Mimedx (MDXG) Amortizatization of Intangibles (2020 - 2025)
Mimedx (MDXG) reported Amortizatization of Intangibles of $24000.0 for Q1 2025, up 9.09% on a YoY basis from $22000.0 in Q1 2024, and up 9.09% sequentially from $22000.0 in Q1 2024.
Mimedx (MDXG) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Mimedx (MDXG) has 6 years of Amortizatization of Intangibles data on file, last reported at $24000.0 in Q1 2025.
- For the quarter ending Q1 2025, Amortizatization of Intangibles rose 9.09% year-over-year to $24000.0; the trailing twelve-month figure through Mar 2025 stood at $96000.0 (up 3.23% YoY), and the FY2023 full-year result was $93000.0, up 1.09% from the prior year.
- Amortizatization of Intangibles grew to $24000.0 in Q1 2025, from $22000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $27000.0 in Q3 2023 to a low of $17000.0 in Q1 2021.
- A 5-year average of $22285.7 and a median of $22500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles jumped 140.0% in 2021 and retreated 12.5% in 2023, its largest moves.
- Tracing MDXG's Amortizatization of Intangibles over 5 years: stood at $24000.0 in 2021, then slipped by 4.17% to $23000.0 in 2022, then changed by 0.0% to $23000.0 in 2023, then slipped by 4.35% to $22000.0 in 2024, then advanced by 9.09% to $24000.0 in 2025.
- Business Quant data shows MDXG's Amortizatization of Intangibles at $24000.0 in Q1 2025, $22000.0 in Q1 2024, and $23000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Mimedx | 635.35 Mn | 475.58 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 24,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 22,000.00 |
| Mar 31, 2022 | 22,000.00 |